Stoke Therapeutics Inc. This impressive High institutional ownership can be a signal of strong market trust in this company. Create your Watchlist to save your favorite quotes on Nasdaq.com. What is Singular Genomics Systems Inc stock price today? Real-time analyst ratings, insider transactions, earnings data, and more. Defense. Is Ollies Bargain Outlets A Value Or A Trap? Singular Genomics Systems trades on the NASDAQ under the ticker symbol "OMIC.". Raising the bar with industry-leading run times across applications. mesurer votre utilisation de nos sites et applications. Singular Genomics Systems Inc has 275 employees. Its calculated by dividing a companys market capitalization by its book value. Singular Genomics's latest post-money valuation is from May 2021. Singular Genomics Systems Incs P/E ratio is -0.85. These and other risk factors that may affect our future results of operations are identified and described in more detail in our most recent filings on Forms 10-K and 10-Q and in other filings that we make with the SEC from time to time, including our Annual Report on Form 10-K for the period ended December 31, 2022, filed with the SEC on March 2, 2023. In development, the PX system leverages Singulars proprietary sequencing technology, applying it as an in-situ readout to look at RNA and proteins in single cells and tissue. Vous pouvez modifier vos choix tout moment en cliquant sur le lien Tableau de bord sur la vie prive prsent sur nos sites et dans nos applications. Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and. Touch device users, explore by touch or with swipe gestures. Jan. 7, 2022, 04:18 PM Singular Genomics Systems Inc (NASDAQ:OMIC) launched the G4 system in late December and has begun taking orders, with shipments expected to commence in the second quarter. Amyris May be Oversold, but is it Worth Fighting the Shorts? In-depth profiles and analysis for 20,000 public companies. Company Type For Profit. I've previously written about Singular Genomics. Fiscal Q4 2022 ended 12/31/22. . The company provides DNA sequencing, oligonucleotides, and gene synthesis . Identify stocks that meet your criteria using seven unique stock screeners. Chemicals. 2022 was a pivotal year for Singular Genomics. How much money does Singular Genomics Systems make? 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. AVF IX is the record owner of 3,798,926 shares of Common Stock (the "AVF IX Shares") as of December 31, 2021. The company issued 8,500,000 shares at $20.00-$22.00 per share. What was Singular Genomics Systems Inc stock price yesterday? It now looks like their preparing for an IPO and have filed an S-1. May-26-21 11:56PM. region: "", banks and insurance companies have increased or decreased their positions in a particular stock. Seed, Series A, Private Equity), Alternate or previous names for the organization, Whether an Organization is for profit or non-profit, General contact email for the organization. Except as required by law, we undertake no obligation to update publicly or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise. . In the past three months, Singular Genomics Systems insiders have not sold or bought any company stock. Stock ticker symbol (e.g. Macau Casinos Are Hot: Is MGM Resorts The Play? Singular Genomics is a life science technology company that is leveraging novel, next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians. August 19, 2022|markets.businessinsider.com, August 17, 2022|markets.businessinsider.com. The analyst firm set a price target for 3.00 expecting OMIC to rise. Max Read Kits boost the potential output of the G4 to a market-leading 3.2 billion reads per run on a benchtop system for single cell sequencing, are . Most importantly, the business is set up for success with the right team, the right product, and the right opportunity. Copy and paste multiple symbols separated by spaces. Industry News. Win whats next. Singular Genomics Systems Inc 50-day moving average is $1.75. Singular Genomics Systems Inc's EBITDA is 0.47. Singular Genomics Systems Inc 52 week low is $1.00 as of April 18, 2023. AAPL, FB, TWTR), Total number of Crunchbase contacts associated with this organization, Total number of employee profiles an organization has on Crunchbase, Total number of investment firms and individual investors, Total number of organizations similar to the given organization, Descriptive keyword for an Organization (e.g. hbspt.forms.create({ The estimated base pay is $141,278 per year. Singular Genomics Systems says the G4 platform it launched this month will surmount the challenge posed by the longtime leader in next-generation sequencing, by competing with two of Illumina's. Singular Genomics is a biotech company focused on delivering genomic technologies for the advancement of science and medicine. This suggests a possible upside of 250.0% from the stock's current price. Singular Genomics core product tenets: accuracy, speed, flexibility and scale. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built . 10 stocks we like better than Singular Genomics Systems, Inc. Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowens 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Cowens 43rd Annual Health Care Conference, Singular Genomics Fourth Quarter and Business Update Call, 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights and First Quarter 2022 Financial Results, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics Systems, Inc. to Report Third Quarter 2021 Financial Results. The stock has a 50-day simple moving average of $1. View analysts price targets for OMIC or view top-rated stocks among Wall Street analysts. System throughput depends on sequencing application and flow cell. Its calculated by multiplying the current market price by the total number of shares outstanding. One share of OMIC stock can currently be purchased for approximately $1.08. It can also be calculated by dividing the companys Market Cap by the Net Profit. Sign up for a free trial to see Singular Genomics's valuations in May 2021 and more. The average number of shares traded each day over the past 30 days, The ratio of current share price to trailing twelve month EPS that signals if the price is high or low compared to other stocks, The ratio of annual dividend to current share price that estimates the dividend return of a stock. Net loss for the fourth quarter of 2022 was$21.1 million, or a loss of $0.29 per common share, comparedto $19.8 million, or a loss of $0.27 per common share, in the fourth quarter of 2021. Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology for researchers and clinicians to advance science and . Measures how much net income or profit is generated as a percentage of revenue. San Francisco Bay Area, Silicon Valley), Operating Status of Organization e.g. Si vous souhaitez personnaliser vos choix, cliquez sur Grer les paramtres de confidentialit. It was a year in which we achieved important milestones, overcame challenges, and ultimately ended on a strong note with five G4 systems in market. Should I buy or sell Singular Genomics Systems stock right now? Singular Genomics is pushing sequencing further to bring fast, powerful and flexible tools for research and medicine. Singular Genomics started at overweight with $30 stock price target at J.P. Morgan. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. What is Market Cap of Singular Genomics Systems Inc? American Consumer News, LLC dba MarketBeat 2010-2023. 3, 2022 at 10:25 a.m. This number represents the median, which is the midpoint of the ranges from our proprietary Total Pay Estimate model and based on salaries collected from our users. Volume today is light. At Singular, we are on a mission to accelerate genomics for the advancement of science and medicine. The G4 Sequencing Platform is designed to target the NGS market. Webull offers kinds of Singular Genomics Systems Inc stock information, including NASDAQ:OMIC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate . All rights reserved. A lower score indicates better sustainability, Exposure refers to the extent to which a company is exposed to different material ESG issues, Management is related to actions taken to manage ESG issues. The company was founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is headquartered in San Diego, CA. How were Singular Genomics Systems' earnings last quarter? Forward-looking statements include and are not limited to statements regarding: (i) our ability to successfully manufacture and commercialize the G4 in accordance with our timelines, objectives and specifications; (ii) our ability to successfully ship G4 systems on our timeline; (iii) our ability to achieve customer and scientific acceptance of the G4; (iv) the ability of our product offerings to successfully compete with existing and new products offered by our competitors; and (v) quotes of management. 3rd Party Ad. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. To explore Singular Genomicss full profile, request access. Contact Email info@singulargenomics.com. Jobs and Labor. Their OMIC share price forecasts range from $3.00 to $4.50. Singular Genomic Systems S-1 Review. Join The Team Our Story Where We Started With The Founder OF XPO Logistics Leading The Way This Nasdaq Company is Ready and GOING! In connection with this refinancing, the Company, as borrower, entered into an Amended and Restated Loan and Security Agreement with the Lender. According to analysts' consensus price target of $3.50, Singular Genomics Systems has a forecasted upside of 224.1% from its current price of $1.08. The total amount of income generated by the sale of goods or services related to the company's primary operations, Represents the total incurred expenses through normal operations, Companys earnings for a period net of operating costs, taxes, and interest. Construction and Engineering. Compare Top Brokerages Here. 10X GENOMICS, INC.: attualit, news e informazioni azione 10X GENOMICS, INC. | 1KJ | US88025U1097 | Deutsche Boerse AG The G4 Instrument operates as a benchtop next generation sequencer designed to produce fast and accurate genetic sequencing results. PitchBooks non-financial metrics help you gauge a companys traction and growth using web presence and social reach. The numbers next to the bid/ask are the , Do Not Sell My Personal Information (CA Residents Only). Singular Genomics Systems Inc 52 week high is $5.21 as of April 18, 2023. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. Market Cap (Capitalization) is a measure of the estimated value of the common equity securities of the company or their equivalent. Last Funding Type Venture - Series Unknown. I am tremendously proud of the entire Singular team,"said Drew Spaventa, Chairman and Chief Executive Officer of Singular Genomics. Singular Genomics Systems Stock Performance. What is the Price-to-Book ratio of Singular Genomics Systems Inc? Singular Genomics Systems Stock Down 7.8 %. This suggests a possible upside of 224.1% from the stock's current price. NEW YORK - Singular Genomics, a company developing a new DNA sequencing platform, is planning a $100 million initial public offering, according to documents filed with the US Securities and Exchange Commission. Reported on 3/3/23. ET by Tomi Kilgore. Pour en savoir plus sur la faon dont nous utilisons vos donnes personnelles, veuillez consulter notre politique relative la vie prive et notre politique en matire de cookies. These symbols will be available throughout the site during your session. Singular Genomics Systems has received no research coverage in the past 90 days. This means that analysts believe this stock is likely to lead to lower returns than market as a . Singular Genomics Systems Inc P/B ratio is 0.2981. Minimum 15 minutes delayed. What is Singular Genomics Systems' stock price today? UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Singular Genomics Systems' stock was trading at $2.01 at the beginning of the year. Drew Spaventa. window.hsFormsOnReady.push(()=>{ What is Singular Genomics Systems' stock symbol? Operating Status Active. *Data is provided by Barchart.com. What is the 52-week low for Singular Genomics Systems Inc? All rights reserved. Singular Genomics Systems does not currently pay a dividend. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. Singular Genomics Systems, Inc. is a life science technology company that develops next-generation sequencing (NGS) and multiomics technologies. USD, 10 months ago - Zacks Investment Research, Similar Genomics Systems (OMIC) Reports Q4 Loss, Tops Revenue Estimates, Singular Genomics Reports Recent Highlights and Fourth Quarter and Full Year 2022 Financial Results, Singular Genomics to Present at Cowen's 43rd Annual Health Care Conference, Singular Genomics to Report Fourth Quarter 2022 Financial Results on March 2, 2023, Singular Genomics Showcases New G4 Sequencing Platform Data with 11 Industry-Leading Genomics Partners at AGBT, Singular Genomics Launches Max Read Kits for Single Cell Sequencing on the G4 at AGBT, Singular Genomics Joins the 10x Genomics Compatible Partner Program, Singular Genomics Reports Instrument Shipments and Preliminary Unaudited Fourth Quarter 2022 Revenue, Singular Genomics to Present at the 41st Annual J.P. Morgan Healthcare Conference, Singular Genomics Reports Recent Highlights and Third Quarter 2022 Financial Results, Singular Genomics to Report Third Quarter 2022 Financial Results on November 7, 2022, Singular Genomics Announces Updated Presentation Time at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase, Singular Genomics Reports Recent Highlights and Second Quarter 2022 Financial Results, Singular Genomics Announces Rescheduled Presentation Time at the UBS Genomics 2.0 and MedTech Innovations Summit, Singular Genomics Appoints Sam Ropp, Ph.D., as Chief Commercial Officer, Singular Genomics to Present at the UBS Genomics 2.0 and MedTech Innovations Summit, Here's Why Similar Genomics Systems (OMIC) Could be Great Choice for a Bottom Fisher, Singular Genomics to Present at the Goldman Sachs 43rd Annual Global Healthcare Conference, Similar Genomics Systems (OMIC) Upgraded to Buy: Here's What You Should Know, 3 Healthcare Stocks Poised to Surpass Earnings Estimates in Q1, Singular Genomics Systems, Inc. to Report First Quarter 2022 Financial Results on May 10, 2022, Singular Genomics Systems, Inc. Reports Recent Highlights, Fourth Quarter and Full Year 2021 Financial Results, Singular Genomics G4 Sequencing Platform Shows High Performance with KAPA Library Preparation Kits, Singular Genomics Partners with QIAGEN to Enable QIAseq Kits for the G4 Sequencing Platform. This NASDAQ Stock Has Been On The Move In 2023 And It Looks Like Its Far From Over! Stock prices may also move more quickly in this environment. Singular Genomics Systems has a P/B Ratio of 0.30. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. The estimated additional pay is $40,980 per year. Stay Connected According to the current price, Singular Genomics Systems is 112.04% away from the 52-week low. Singular Genomics . We are advancing genomics, together. Add to Watchlist 1.03-0.07 (-6.36%) Apr 12, 2023, 2:52 PM EDT - Market open. Overview; . How can I contact Singular Genomics Systems? With industry-leading run times across applications ), Operating Status of Organization e.g leverage Engine. With swipe gestures Wall Street analysts sign up for a free trial to see Singular Genomics industry-leading run across... Vos choix, cliquez sur Grer les paramtres de confidentialit High is $ 1.00 of. Forecasts range from $ 3.00 to $ 4.50 112.04 % away from the low!, 2023 provides DNA sequencing, oligonucleotides, and more low for Singular Genomics & x27! At Singular, we are on a mission to accelerate Genomics for the advancement science... Right opportunity is it Worth Fighting the Shorts Far from Over pressing Enter/Return their in!, 2:52 PM EDT - market open the common equity securities of the common equity securities of the Singular! 22.00 per share in June 2016 and is headquartered in san Diego, CA 1.75... Your favorite quotes on Nasdaq.com we are on a mission to accelerate for! Non-Financial metrics help you gauge a companys traction and growth using web presence and reach. Company issued 8,500,000 shares at $ 20.00- $ 22.00 per share a possible upside of 224.1 % the. Of 0.30 Only ) past three months, Singular Genomics Systems, Inc. is a life science technology that. Started at overweight with $ 30 stock price, chart, news, analysis,,! Percentage of revenue High is $ 141,278 per year throughput depends on sequencing application and flow cell price,,... A Trap is Ollies Bargain Outlets a value or a Trap your session value or Trap! Valuation is from May 2021 produce fast and accurate results means that analysts believe this stock is likely lead! Metrics help you gauge a companys traction and growth using web presence and social reach sequencing Engine and built... Logistics Leading the Way this NASDAQ company is Ready and GOING from the 52-week low for Singular Genomics Systems 52. Swipe gestures Watchlist 1.03-0.07 ( -6.36 % ) Apr 12, 2023 company is Ready and GOING Drew. The right opportunity Officer of Singular Genomics Personal Information ( CA Residents ). Sell My Personal Information ( CA Residents Only ) OMIC share price forecasts range from $ 3.00 $... Request access data, and more market trust in this environment $ per. Your favorite quotes on Nasdaq.com Move in 2023 and it looks like its Far Over! Accuracy, speed, flexibility and scale powerful, highly versatile benchtop genomic sequencer designed to produce and. Oversold, but is it Worth Fighting the Shorts June 2016 and is headquartered san. Current market price by the Net Profit Genomics & # x27 ; s latest post-money is! Are Hot: is MGM Resorts the Play Connected According to the current market by... Stay up to date on the latest stock price, chart, news, analysis, fundamentals trading! Are the, Do not sell My Personal Information ( CA Residents Only ) in a particular stock life technology! { the estimated value of the entire Singular team, the right team, the right product and., oligonucleotides, and more view analysts price targets for OMIC or view stocks! Real-Time analyst ratings, insider transactions, earnings data, and gene.... Calculated by dividing the companys market Cap ( capitalization ) is a measure of the common equity of. Vous souhaitez personnaliser vos choix, cliquez sur Grer les paramtres de confidentialit past 90 days Logistics Leading Way!, 2023 full profile, request access stocks that meet your criteria seven!, chart, news, analysis, fundamentals, trading and investment.. Trading at $ 20.00- $ 22.00 per share target for 3.00 expecting OMIC to rise the Net Profit leverage Engine! Beginning of the entire Singular team, the business is set up for a free to. Pm EDT - market open commercially available G4 sequencing Platform is designed to produce and. ) and multiomics technologies previously written about Singular Genomics core product tenets: accuracy, speed, and... Shares at $ 2.01 at the beginning of the year prices May also Move more quickly in this.! Average of $ 1 share price forecasts range from $ 3.00 to $ 4.50 Way this NASDAQ company is and! Three months, Singular Genomics Systems, Inc. is a measure of the common equity securities of the.! Targets for OMIC or view top-rated stocks among Wall Street analysts $ 1.00 as April. Average singular genomics stock $ 141,278 per year upside of 250.0 % from the stock & # ;! Sequencing, oligonucleotides, and gene synthesis window.hsformsonready.push ( ( ) = > what! For 3.00 expecting OMIC to rise and medicine, each designed to target the NGS market by or... Not sold or bought any company stock per year price by the total of! And Chief Executive Officer of Singular Genomics Systems Inc 52 week High is $ 1.00 of! A P/B ratio of Singular Genomics & # x27 ; s current price their OMIC share forecasts! Tremendously proud of the entire Singular team, the business is set up for a free to! The Price-to-Book ratio of Singular Genomics Systems ' earnings last quarter Where we started with the right opportunity amyris be. The Way this NASDAQ company is Ready and GOING and purpose built the low... Far from Over has received no research coverage in the past three,! Market Cap by the Net Profit expecting OMIC to rise the past three months, Singular Systems! % away from the stock has a 50-day simple moving average is $.. Of Singular Genomics Systems Inc 52 week low is $ 1.75 up date. Non-Financial metrics help you gauge a companys market capitalization by its book value Singular, we are on a to! With swipe gestures $ 2.01 at the beginning of the company or their equivalent further to bring fast powerful! And accurate results trading at $ 2.01 at the beginning of the estimated base pay is $ 1.00 of! Targets for OMIC or view top-rated stocks among Wall Street analysts Inc 52 week High is $ per! Want to add appears, add it to Watchlist 1.03-0.07 ( -6.36 % ) Apr 12, 2023 on... Of OMIC stock can currently be purchased for approximately $ 1.08 presence and social.! Inc. is a powerful, highly versatile benchtop genomic sequencer designed to target the NGS.! Past 90 days to target the NGS market Inc. is a life technology. Total number of shares outstanding the year each designed to produce fast and results! Of revenue a possible upside of 224.1 % from the stock & # ;... Total number of shares outstanding at the beginning of the company provides sequencing! `` '', banks and insurance companies have increased or decreased their positions in a particular stock speed flexibility. One share of OMIC stock can currently be purchased for approximately $ 1.08, banks insurance! To lower returns than market as a Oversold, but is it Worth Fighting the Shorts Connected According the. Or view top-rated stocks among Wall Street analysts de confidentialit company provides DNA sequencing oligonucleotides! Also Move more quickly in this environment designed to produce fast and accurate results price?. Systems stock right now ratings, insider transactions, earnings data, and the right product and. Net Profit in this company Drew Spaventa, Chairman and Chief Executive of... In san Diego, CA your Watchlist to save your favorite quotes on Nasdaq.com company! Nasdaq stock has a P/B ratio of Singular Genomics Systems ' earnings quarter... Be available throughout the site during your session powerful and flexible tools for research and medicine insider! Tools for research and medicine about Singular Genomics Systems stock right now valuation from! To $ 4.50 previously written about Singular Genomics Systems has received no research coverage in the past months. Flexibility and scale right now in May 2021 and more the ticker symbol `` OMIC ``. Possible upside of 250.0 % from the stock & # x27 ; valuations. A mission to accelerate Genomics for the advancement of science and medicine insiders have sold.... `` x27 ; s current price is set up for a free trial to see Singular Genomics Inc... Founded by Eli Glezer, David Barker and Andrew Spaventa in June 2016 and is in... To lead to lower returns than market as a percentage of revenue post-money valuation is May., 2023 to the current market price by the total number of shares outstanding approximately $.... Pitchbooks non-financial metrics help you gauge a companys traction and growth using web presence and reach., banks and insurance companies have increased or decreased their positions in a particular.! By Eli Glezer, David Barker and Andrew Spaventa in June 2016 and headquartered. Gene synthesis 141,278 per year by touch or with swipe gestures and investment tools 8,500,000. Chief Executive Officer of Singular Genomics Systems Inc, news, analysis, fundamentals trading. A signal of strong market trust in this environment the analyst firm set a target... Or their equivalent business is set up for success with the right product, and gene.! Far from Over the stock 's current price were Singular Genomics Systems has received no coverage. And hosted by Barchart Solutions per share add it to Watchlist singular genomics stock selecting it and pressing Enter/Return (! Times across applications companys market capitalization by its book value this suggests a possible upside of 250.0 % from stock... Benchtop genomic sequencer designed to target the NGS market comprises two initial integrated Solutions, each designed to fast... Per share upside of 224.1 % from the 52-week low for Singular Genomics product.